Oral mucosal stigmata in hereditary-cancer syndromes: From germline mutations to distinctive clinical phenotypes and tailored therapies Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Sunday, February 07, 2016

Oral mucosal stigmata in hereditary-cancer syndromes: From germline mutations to distinctive clinical phenotypes and tailored therapies



abstract
 

Highlights

Several familial-cancer syndromes include distinctive oral mucosal lesions.
Their genetic background involve germline mutations in tumor suppressor genes.
A multidisciplinary approach is crucial for management of the gene-carriers probands.
An early onset of oral disease may lead to genetic testing in suspected probands.
The advancements in this field lead to the development of targeted therapies.


Abstract
Numerous familial tumor syndromes are associated with distinctive oral mucosal findings, which may make possible an early diagnosis as an efficacious marker for the risk of developing visceral malignancies. In detail, Familial Adenomatous Polyposis (FAP), Gardner syndrome, Peutz-Jeghers syndrome, Cowden Syndrome, Gorlin Syndrome, Lynch/Muir-Torre Syndrome and Multiple Endocrine Neoplasia show specific lesions of the oral mucosa and other distinct clinical and molecular features. The common genetic background of the above mentioned syndromes involve germline mutations in tumor suppressor genes, such as APC, PTEN, PTCH1, STK11, RET, clearly implied in both ectodermal and mesodermal differentiation, being the oral mucosal and dental stigmata frequently associated in the specific clinical phenotypes. The oral and maxillofacial manifestations of these syndromes may become visible several years before the intestinal lesions,
constituting a clinical marker that is predictive for the development of intestinal polyps and/or other visceral malignancies. A multidisciplinary approach is therefore necessary for both clinical diagnosis and management of the gene-carriers probands and their family members who have to be referred for genetic testing or have to be investigated for the presence of visceral cancers.

Abbreviations

  • HNPCC, Hereditary Non-Polyposis Colorectal Cancer;
  • MTS, Muir-Torre Syndrome;
  • MEN, Multiple Endocrine Neoplasia;
  • FAP, Familial Adenomatous Polyposis;
  • BCC, Basal Cell Carcinoma

Keywords

  • Familial Adenomatous Polyposis (FAP);
  • Gardner syndrome;
  • Peutz-Jeghers syndrome;
  • Cowden Syndrome;
  • Gorlin Syndrome;
  • Multiple Endocrine Neoplasia;
  • Lynch/Muir-Torre Syndrome;
  • Ameloblastoma;
  • Odontogenic keratocystic tumors;
  • Fordyce granules

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.